B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE explained in plain language.
Never miss a new study
Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE trials appear
Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for Tough-to-Treat blood cancer
Disease control OngoingThis study tests whether adding a targeted drug called tafasitamab to standard chemotherapy can improve treatment for adults newly diagnosed with a fast-growing blood cancer (Ph- B-ALL). About 32 adults who cannot receive standard intensive chemo will get the combination. The goa…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC
-
Leukemia drug combo shows promise in major trial
Disease control OngoingThis study tests whether adding the immunotherapy drug blinatumomab to standard chemotherapy helps adults with a certain type of leukemia live longer and stay cancer-free longer. About 488 newly diagnosed patients took part. The goal is to see if the combination works better than…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 03, 2026 12:03 UTC